Speakers at EBSA Conference 2024 and Preconference courses

EBSA Conference 2024 and Preconference courses

About the speakers

  1. Alina Teuscher

    Alina Teuscher

    After finishing her PhD at the ETH Zurich in the field of molecular biology of aging, Alina changed her research direction and started working at the State Laboratory Basel-Stadt. There she works on projects for the Swiss Federal Office of Public Health on the integrity of the containment to prevent the release of genetically modified or pathogenic organisms into the environment. She is currently focusing on a project on the potential risks of handling replication-deficient lentiviral vectors used in medicine and research.
    Present Professional Position
    • Since 2021 Research Associate, Biosafety Laboratory, State Laboratory Basel-City, Switzerland.
      Kantonales Laboratorium (bs.ch)
    Academic Education and Degrees
    • 2016 - 2021 Ph.D. in molecular biology and genetics of aging. Prof. Collin Ewald, ETH Zurich, Switzerland.
    • 2014 - 2016 M.Sc. in Biology, University of Cologne, Germany. Specialization in genetics and cell biology.
    • 2010 - 2013 B.Sc. in Biology, University of Cologne, Germany.
  2. Clara Posthuma

    Clara Posthuma

    Clara Posthuma studied biology at the University of Groningen (Netherlands), and graduated in Molecular Biology. After obtaining her PhD at the University of Amsterdam in 2001, she worked for many years at the Leiden University Medical Center as postdoc and senior researcher in molecular virology. During this period, she worked on fundamental and applied research topics addressing various aspects of nidovirus replication. Amongst these were antiviral drug research against SARS- and MERS-CoV and  fundamental research on viral RNA replication, using reverse genetics, biochemistry and next generation sequencing. In 2019, Clara joined the secretariat of the Netherlands Commission on Genetic Modification (COGEM). COGEM advises the Dutch government on risks to human health and the environment of genetically modified organisms (GMO’s), and informs the government of ethical and societal issues linked to genetic modification. As a scientific secretary, Clara coordinates the subcommittee of Medical and Veterinary Aspects.

  3. Giulio Zanaroli

  4. Hulda R. Jonsdottir

    Hulda R. Jonsdottir

    Professional experience:
    Currently a Co-Principal Investigator at Spiez Laboratory in Spiez, Switzerland with a focus on Henipavirus-host interactions and antivirals, as well as a Visiting Lecturer in Medical Virology at the University of Iceland in Reykjavík, Iceland. Previous positions include post-doctoral fellowships in respiratory toxicology (2017-2019) and virology (2016-2017) at the University of Bern.

    Summary of research activities:
    Dr. Jonsdottir's research activities span from developing in vitro culture systems for studying airway structure and function, focusing on the role of bronchial cells in fibrosis, to establishing transgenic organotypic airway cultures for respiratory virus research. She contributed to the initial characterization of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and has continued to contribute to identifying antivirals against coronaviruses, including SARS-CoV-2. Her postdoctoral work in respiratory toxicology explored the effects of jet turbine exhaust on human airways using organotypic airway cultures. Currently, she investigates host responses to highly pathogenic viruses, focusing on Henipaviruses, and evaluates novel antiviral therapies and vaccines. Future goals include advancing three-dimensional cell culture systems for studying Henipavirus-host interactions and other highly pathogenic viruses.

    Education:

    • Doctorate in biology, 2016 - ETH Zurich, Zürich, Switzerland
      Thesis: Genetic modification of primary human airway epithelial cultures – a novel platform to study respiratory pathogens
    • Master’s degree in biomedical sciences, 2012 – University of Iceland, Reykjavík, Iceland
      Thesis: Epithelial-to-mesenchymal transition in human lung epithelial cells • Bachelor’s degree in molecular biology, 2010 – University of Bergen, Bergen, Norway

    Skills:

    • Containment training at both BSL-3 and -4 levels
    • Expertise in molecular virology, genetic modification techniques, antiviral research, cellular assays, three-dimensional cell culture, histology, etc
    • Experience in diagnostic processes for viruses and bacteria
    • Proficient in multiple languages - Icelandic, English, Norwegian (fluent), Danish, Swedish, German (intermediate)
    • Strong communicator with a keen interest in dissemination of scientific information
  5. Jaspreet Chana

    Jaspreet Chana

    Principal Consultant at ERM

    Jaspreet is a Principal Safety Consultant, principally with a background in Chemical and Process Engineering, she has worked in high risk, critical consequences industries for over 15 years including nuclear, biosafety and oil and gas. She has a vast array of experience by working on a variety of different projects and taking on diverse roles. Her experience covers technical safety and loss prevention areas such as Process Hazard Analysis, Safety Integrity Level (SIL) studies, SIL verification studies and Functional Safety Management Systems

    As the Biosafety Lead, her expertise lies in the management and implementation of process safety within the biocontainment industry specialising in the application of IEC 61511 in BSL-3 and BSL-4 facilities in line with the ISO 35001 framework. She is uniquely placed in understanding the complexities associated with applying process safety in high containment facilities handling dangerous pathogens gaining knowledge and experience through site-based and practical application.

    Qualifications:

    • 2.1 Upper Class MEng (Hons) in Chemical Engineering with Biochemical Engineering at University College London (UCL), London, UK
    • Chartered Engineer with IChemE
    • TÜV Rheinland Functional Safety Engineer (FS Eng)
    • Biosafety Practitioner Level 1 (Accredited by ISTR)
    • IChemE HAZOP Study for Team Leaders and Team Members

    Key Areas of Expertise (within Biosafety):

    • Process Safety
    • Functional Safety
    • Human Factors
    • Risk Assessments
    • ISO 35001 Framework
    • Bow Tie Analysis
  6. Jonathan Kennedy

    Jonathan Kennedy

    CURRENT POSITION AND ROLES
    • 2021-present: Reader in Politics and Global Public Health, QMUL
    • 2021-present: Deputy Director, Centre for Public Health and Policy, QMUL
    • 2019-present: Director, intercalated BSc Global Public Health programme, QMUL
    PREVIOUS POSITIONS AND ROLES
    • 2019-21: Senior Lecturer in Global Public Health, QMUL
    • 2019-21: Director, MSc and MRes Global Public Health programme, QMUL
    • 2016-19: Lecturer in Global Public Health at QMUL
    • 2013-16: Teaching Fellow in International Development, School of Public Policy, UCL
    • 2012-14: Research Associate, Department of Sociology, University of Cambridge
    EDUCATION
    • 2008-12: PhD, Department of Sociology, Cambridge University (passed with no corrections)
    • 2007-08: MPhil in Modern Society and Global Transformation, Cambridge University (1st Class with Special commendation)
    • 2005-07: MA in Global Studies, Freiburg University, KwaZulu-Natal University and Jawaharlal Nehru University (1.5 or “Very good”)
    • 2001-04: BA in History, Nottingham University (1st Class)
    BOOK
    • Jonathan Kennedy (2023): Pathogenesis: How germs made history. Penguin.
    • Sunday Times, Amazon, Waterstones and Good Reads’ books of the year list for 2023; Washington Post, GQ Magazine, and Literary Hub's most anticipated books for 2023; Times and Financial Times’ best summer books 2023; and serialised on BBC Radio 4's Book of the Week.
    • Reviewed in The Economist, Financial Times, Washington Post, Sunday Times, Times, Observer, Guardian, Daily Telegraph, Irish Times, Irish Independent, Spectator, Times Literary Supplement, Nature, New Scientist, New Statesman, Atlantic, New Republic, New Yorker, Boston Globe, Wired, Sydney Morning Herald, Strait Times and Haaretz.
    • Has been or will be translated into 14 languages: Chinese, Arabic, Turkish, Russian, Spanish, Italian, Korean, Greek, Polish, Romanian, Estonian, Czech, Norwegian, and Dutch.
    SELECTED ACADEMIC ARTICLES AND CHAPTERS
    • David McCoy, Stephen Roberts, Salma Daoudi, Jonathan Kennedy, (2023): ‘Global Health Security and the Health-Security Nexus: Principles, Politics and Praxis.’ BMJ Global Health.
    • Obichukwu Iwunna, Jonathan Kennedy, Andrew Harmer (2023): ‘Flexibly funding WHO? An analysis of its donors’ voluntary contributions.’ BMJ Global Health 8(4): e011232
    • Jonathan Kennedy and David McCoy (2020): ‘Malaria Eradication’, Lancet 395(10233): e70.
    • Jonathan Kennedy, David McCoy and Joseph Gafton (2020): ‘The International Arms Trade and Global Health’, in Solomon Benatar and Gillian Brock (eds.) Global Health: Ethical Challenges (Cambridge, UK: Cambridge University Press): 182-194.
    • Andrew Harmer and Jonathan Kennedy (2020): ‘International Development and Global Health’, in Colin McInnes, Kelly Lee and Jeremy Youde (eds.) Oxford Handbook of Global Health Politics (Oxford, UK: Oxford University Press): 217-236.
    • Jonathan Kennedy, Marian Abouzeid, Samer Jabbour and David McCoy (2019): ‘Militaries and global health,’ Lancet 394(10202): 916-917.
    • Jonathan Kennedy (2019): ‘Populism and vaccine hesitancy in Europe: An analysis of national level data,’ European Journal of Public Health 29(3):512-16.
    • Jonathan Kennedy, Andrew Harmer and David McCoy (2017): ‘The political determinants of the cholera outbreak in Yemen’, Lancet Global Health 5(11): e970-71.
    • Jonathan Kennedy and Domna Michailidou (2017): ‘Divergent policy responses to increasing vaccine scepticism in southern Europe’, Lancet Infectious Diseases 17(9): 900.
    • Jonathan Kennedy and David McCoy (2017): ‘The WHO and the health crisis among the Rohingya people of Myanmar’, Lancet 389(10071): 802-803.
    • Jonathan Kennedy (2017): ‘How Drone Strikes and a Fake Vaccination Program Inhibited Polio Eradication in Pakistan’, International Journal of Health Services 47(4): 807-825.
    • Keertichandra Rajan, Jonathan Kennedy and Lawrence King (2013): ‘Is Wealthier Always Healthier in Poor Countries? The Health Effects of Income, Inequality, Poverty, and Literacy in India,’ Social Science and Medicine 88: 98-107.

    • For a complete list of my publications see here.
    SELECTED PROFESSIONAL REPORTS
    • Centre for Public Interest Communications and the United Nations Verified initiative (2020). A practitioner’s guide to the principles of COVID-19 vaccine communications. (Named contributor)
    • Kristi Arthur, Jonathan Kennedy and Anubha Prakash (2007): ‘A Case Study of the Community Monitoring Project: Raichur District, Northern Karnataka,’ UNICEF India Working Paper.
    SELECTED RESEARCH FUNDING
    • 2020-24: ESRC/LISS-DTP, Global Health Governance in Syria and Yemen (£120,000, PhD studentship for Aida Hassan)
    • 2019: Butterfield Award for Research on Japan (£3,600, PI)
    • 2018-19: QMUL Global Challenges Research Fund Internal Networking Grant for building links with American University of Beirut (£12,000, PI = David McCoy)
    • 2018: London Bridge Terror Attack Response Evaluation (£13,000, Co-PI)
    • 2015: UCL Grand Challenges grant to cover fieldwork costs in Syria and Pakistan for project looking at public health provision in countries affected by civil war (£5,000, PI)
    • 2014: Cambridge University Philomothia Social Sciences Research Grant to employ a research assistant to help collect data for project on farmers’ suicides in India (£1,000, PI)
    TEACHING
    • US-UK Fulbright Commission’s Global Challenges Teaching Award 2022-23. One of 3 UK based winners. For developing a virtual exchange between global public health students and pre-med students at UC Santa Cruz focused on the theme of pandemics.
    • QMUL ‘President and Principal’s Prize’ for development of the virtual exchange. With Danielle Thibodeau of QM Academy and Ceri Bevan of QM Global Opportunities Office in 2023.
    • I currently teach modules on ‘Health Inequalities and Social Determinants of Health’ (MSc) and ‘Global Health, International Law and Governance’ (levels 6 and 7).
    MEDIA
    • I have written on politics and health op-eds for a variety of media outlets including The Guardian, London Review of Books, Readers Digest, Al Jazeera, El Pais, Les Echos, Project Syndicate, and Politico.
    • I have given TV interviews for CNN, BBC World TV, and Al Jazeera, and radio interviews for BBC Radio 4’s World at One, The World Tonight, and Inside Science, RTE Radio 1’s Ray D’Arcy Show, RNZ’s Saturday Mornings with Kim Hill, CBC’s Sunday Magazine, Public Radio International’s The World, Sveriges Radio (Swedish National Radio), and Yle (Finnish National Radio).
    LANGUAGE SKILLS
    • English – Mother Tongue
    • German and Norwegian – Basic conversational and reading
  7. Julia Rieger

    Technical Head of the BSL 3 Laboratory and dissection room for high-risk pathogens, Institute of Pathology, Medical University of Graz

    Work experience
    Since 2024      Professional Course in Biorisk Management
    Since 2023      Deputy biosafety officer, Institute of Pathology, Medical University Graz
    Since 2021        Technical Head and Quality Management Officer of the BSL 3 environment, Institute of Pathology, Medical University Graz
    Since 2020      Fire protection officer for the BSL 3 Laboratory, Institute of Pathology
    Since 2019      Part of the research group Prof. Dr. Kurt Zatloukal, Institute of Pathology, Medical University Graz
    2016-2019      Employment Institute of Analytical Chemistry, Karl-Franzens University Graz
    Since 2015      Studies in „Environmental and Systems Sciences with focus on Natural Sciences Technologies“ NAWI Graz

    2012-2014      Plastics engineer, Greiner Packaging, Kremsmünster

  8. Karen Gjendal

    Karen Gjendal

    I am responsible for Biosafety and Biosecurity at Bavarian Nordic, a vaccine company with a commercial-scale manufacturing facility in Kvistgaard, Denmark. Bavarian Nordic manufacture, analyze, and release sterile vaccines for use in humans in accordance with full EU cGMP requirements. Currently, Bavarian Nordic produces Smallpox, Rabies, Tick-Borne Encephalitis and Ebola vaccines, with more products in the pipeline, with the focus of developing innovative life-saving vaccines. As the Biosafety Officer at Bavarian Nordic, I am responsible for ensuring a proper Biorisk management program and implement the necessary requirements to control safety and security risks associated with the handling, storage and disposal of biological agents and toxins in the production facility.

    EDUCATION
    2021- Biorisk Management Mentee of Vipsit LLC
    2015-2018 PhD-Fellow, University of Copenhagen
    2014 Veterinary Medicine, University of Copenhagen

    EXPERIENCE
    2021- Biosafety Officer, Bavarian Nordic
    2020-2021 Environmental Supporter, Bavarian Nordic
    2019 Project Coordinator for evaluation of medical devices, SAXOCON A/S
    2019 Reviewer for the journal Laboratory Animals
    2018 Research assistant, Novo Nordisk A/S (Leave of absence from PhD)
    2015-2018 PhD fellow, University of Copenhagen
    2014 Research assistant, Novo Nordisk A/S

    COURSES AND MEMBERSHIPS within Biorisk Management
    2023 ABSA Preconference Course, Advanced BSL-3 Facility Operations
    2023 ABSA Preconference Course, Facility Commissioning and Recommissioning for BSL-3 Laboratory
    2023 ABSA Webinar: 11. Large-scale Biosafety
    2022 ABSA International Principles and Practices of Biosafety – Portland July 18-22, 2022
    2022 Nordic Biosafety Network Forum
    2021 ABSA & EBSA Membership
  9. Karen van der Meulen

    Karen van der Meulen

    Academic Education and Degrees

    • Doctor in Veterinary Science (2003), Faculty of Veterinary Medicine, Ghent University, Belgium
    • Doctor in Veterinary Medicine DVM (1998), Faculty of Veterinary Medicine, Ghent University, Belgium

    Present Professional Position

    Senior Biosafety Manager at 3Bio (https://3bio.eu/biosafety/)

    Perseus offers efficient solutions for biorisk management and regulatory compliance.

    Biorisk management covers all aspects of biological safety and security such as risk assessment, containment requirements, training, audit, transport, waste handling and emergency preparedness. Perseus experts can act as external biosafety officers to your organisation. Perseus integrates technical background with an in-depth knowledge of the European regulatory requirements for biological material, including genetically modified organisms. We assist clients in complying with complex regulatory requirements on e.g. contained use, workers protection, import and export, emergency planning, deliberate releases such as field trials and clinical trials, as well as commercial applications.

    Special Remarks

    • Senior expert in biosafety and biotechnology regulation
    • Long term expercience in R&D in life sciences
    • Active member of key biosafety associations and working groups
  10. Kathrin Summermatter

    Kathrin Summermatter

    Head of Biosafety Center
    Managing Director of the Biosafety Level 3 Laboratory, Institute for Infectious Diseases

    The Institute for Infectious Diseases of the University of Bern combines diagnostics, teaching and research under one roof and covers the entire spectrum of microbiological diagnostics.

    Kathrin Summermatter is heading the Biosafety Center and is the managing director of the BSL3 at the Institute for Infectious Diseases. She has been involved in Biosafety for more than 20 years. From 2002 -2019 she was the head of the biosafety department and the deputy director of the Institute of Virology and Immunology (IVI), the Swiss reference lab for highly contagious animal diseases (Biosafety Level 3 and 3Ag Laboratories). In addition, she was the coordinator of BIOSAFETY-Europe. She has been a long-standing member of the European Biosafety Association (EBSA) and the American Biosafety Association (ABSA). In 2003/2004 she was the president of EBSA. She is a member of the International Veterinary Biosafety Workgroup and a board member of the Swiss Biosafety Network (SBNet). She is the chair of the Technical Advisory Biosafety Board (TAG-B) of the WHO and a member of the WHO's Scientific Advisory Group for the Origins of Novel Pathogens (SAGO). She is also the director of the WHO-Collaborating Center for Biosafety and Biosecurity.

    Academic Education and Degrees
    PhD in Biology

  11. Mieke Jansen

  12. Mirjam Schuijff

  13. Ngoc Hoa Chung

    Ngoc Hoa Chung is part of the Biosecurity Office team at the RIVM (National Institute for Public Health and the Environment) in the Netherlands. She is a public health professional and works as a policy officer at the Centre for Environmental Safety and Security at the RIVM. She has a background in biomedical sciences and expertise in emerging infectious diseases in virology, high containment and CBRN.

  14. Patrick Rüdelsheim

    Patrick Rüdelsheim

    Trained as a biologist, Patrick Rüdelsheim started his career in a Dutch seed company. He then joined Plant Genetic Systems N.V., Ghent, Belgium. After being in charge of Product Development and Registration, he was appointed Director Regulatory Affairs and Member of the Board. 

    Following the acquisition of PGS, he became Global Head of Biotechnology Regulatory Affairs for the AgrEvo group and remained in this function during the subsequent creation of Aventis S.A. and the acquisition by Bayer. In this function, he ensured the scientific argumentation for Product Safety and Quality as well as the compliance with all regulatory acquirements related to genetic engineering.

    In 2003, he founded and became General Manager of Perseus BV, a service company focused on bio-safety and related regulatory requirements. Mid 2015, he was co-founder and served as Senior Regulatory Advisor for ABS-int, a multi-disciplinary initiative dedicated to Access and Benefit Sharing requirements for genetic resources. Since 2023, Perseus and ABS-int operate together as 3Bio, in which he acts as Director and Chief Regulatory Officer. In this capacity he offers his extensive and global experience in every aspect of biosafety and biotechnology regulation to a range of users and developers. He lectures on biosafety and regulations at the University of Ghent and the University of Antwerp.

  15. Paul Odinot

    Paul Odinot

    Academic Education and Degrees

    • Master in Medical Biology, Radboud University, Nijmegen, The Netherlands (1991)
    • PhD in Medical Microbiology: Molecular diagnosis and characterization of Yersinia enterocolitica infection, Radboud UMC/University, Nijmegen, The Netherlands (1998)

    Present Professional Position

    • Biosafety coordinator / Biorisk Management Advisor, Utrecht University, The Netherlands, 1998 - present

     Special Remarks 

    • President BVF platform, The Netherlands, 2007 - 2012
    • Chair Education committee, BVF platform, 1999 - 2008
    • Member Disinfection committee, BVF platform, 2010 - present
    • Developer of GRiMaS, Webbased database for registration of GMO riskassessments and legal requirements in The Netherlands

    Dr. Paul Odinot has over 25 years of experience in biosafety, biosecurity and focusing on the legal requirements for e.g. working with (GMO) biological materials, animal byproducts, CITES, the Nagoya protocol and Biocidal Products Regulation.

  16. René Custers

    René Custers

    Academic Education and Degrees

    Msc in molecular sciences, Wageningen university, The Netherlands

    Present Professional Position

    René Custers is regulatory & responsible research manager at VIB (the Flanders Institute for Biotechnology), Belgium. He has more than 25 years of experience in regulatory affairs, biosafety, and the societal and ethical aspects of modern biotechnology. He is an expert in the legislation and safety of GMOs and genome edited organisms and has been very active in the European debate on the regulatory status of genome edited organisms. At VIB he coordinates the institutes’ policies on regulatory compliance, (bio)safety, ethics and integrity. He is also involved in science communication activities to a wider audience. He is a member of the Belgian Biosafety Advisory Council, and member of the board of EU-SAGE (European Sustainable Agriculture through Genome Editing).

  17. Rik Bleijs

    Rik Bleijs

    Dr. Rik Bleijs is head of the Biosecurity Office at the National Institute of Public Health and the Environment (RIVM) in the Netherlands. In 2006 he joined the RIVM and started at the department of Genetically Modified Organisms (GMO) Office where he was involved in the biosafety aspects and the environmental risk assessment of medical and veterinary gene therapy studies. Since 2009 he is involved in the political and scientific implementation of a coordinated biosecurity policy in the Netherlands and the installment of a Biosecurity Office (2013). As head of the Biosecurity Office his main tasks are to advise the different ministries on biosecurity issues, to act as a bridge between the scientific biosafety and biosecurity professionals and the government, and to increase biosecurity and dual-use awareness among students, scientist and laboratory professionals. As a biosecurity expert he is also involved in various international biosecurity projects and initiatives (EU CBRN action plan, Global Health Security Agenda, Global Biosecurity Dialogue, G7, European Biosecurity Regulators Forum, Biological Weapons Convention), thereby supporting the Dutch Ministry of Foreign Affairs. Since 2021 he is co-chair of the International Experts Groups of Biosafety and Biosecurity Regulators (IEGBBR) representing the Netherlands and EU region. In the recent years he organized several capacity building workshops and meetings in Europe, Asia and Africa in the context of international projects to strengthen biosecurity and dual-use assessment global.

  18. Sandhya Dhawan

    Current Employment

    2023 - Present

    Consultant

    Epidemic and Pandemic Preparedness and Prevention
    World Health Organization
    Headquarters, Geneva

    Education

    2023 - 2026

    PhD (candidate)

    Doctor of Philosophy
    (Field of study: Biosafety and biosecurity/Infectious disease epidemiology)
    The Open University, United Kingdom

    Conferences

    2023

    WHO EPP, WPE/WHE Laboratory Biosafety and Biosecurity Regulatory Framework Strengthening, Bucharest, Romania, Oral Presentation

    2023

    WHO EPP, WPE/WHE Technical Advisory Group for Biosafety (TAG-B) Meeting, Istanbul, Turkey, Oral Presentation

    2022

    WHO SEARO Meeting to Review Progress of Implementation of Pandemic Influenza Preparedness (PIP) Partnership Contribution (PC) Funds in South-East Asia Region (SEAR), New Delhi, India [Hybrid]

    2019

    2nd Asia Pacific Rickettsia Conference, Chiang Rai, Thailand (APRC2) Poster and Oral Presentation

  19. Suzanne Loret

    Suzanne Loret

    Academic Education and Degrees:

      • Degree in Biological Sciences (Option: Biochemistry) - UNamur, 1982
      • PhD D Thesis in Sciences (Physiology and Biochemistry) - UNamur, 1990
      • Specialized Diploma in Biosafety Management HEP Rennequin Sualem, in collaboration with the Scientific Institute of Public Health (ISP), 2006
      • IFBA Certification “Biosafety Professional” - July 2016

    Scientific expertise:
    Molecular and Cell Biology (including the use of lentiviral vectors)
    Present Professional Position: Biosafety Officer (since 2005)

    Teaching experience of Biosafety:

    • Annual training of UNamur students and staff
    • Invited instructor for staff training in Biosafety at the Biotech Analis
    • Coordinator and instructor of a 5-days Biosafety course – in French -for professionals at UNamur
      (6 editions: Sept 2014, January 2016, March and December 2017, Sept 2018 and Sept 2019)
    • Invited Instructor at the 5-day international course “Basic Principles of Biosafety” (Ghent - Sept 2015; Antwerp – Sept 2019)
    • Instructor of a 3-days biosafety course at the National University of Rwanda (February 2016)
    • Instructor of a 5-day biosafety course for master students of the St Xavier’s College Kolkata (September 2016)
    • Instructor at the 2019 EBSA pre-conference courses (course M – Disinfection and Disinfectants)

    Involvement in Biosafety associations:

    • Regular member of BBP (Belgian Biosafety Professionals) and EBSA since 2006
    • BBP steering team member for 6 years
    • EBSA council member in 2017 and 2018
    • ETWG member since April 2018
  20. Timo Kehl

    Timo Kehl has been heading the Biological Safety department at the German Cancer Research Center in Heidelberg, Germany since 2018. In addition, since February 2020, he has been leading the DKFZ's Corona task force to manage the coronavirus pandemic situation at DKFZ. Timo Kehl studied biology at the University of Heidelberg and completed his doctoral thesis on "Pancreatic Cancer" in the Department of Genome Modifications and Carcinogenesis at the DKFZ in 2009. He then spent two years as a laboratory head at the Technical University of Munich before returning to the DKFZ in 2011 as a postdoc in the field of applied tumor virology. After two years as a postdoc, he joined the "Biological Safety" department at the DKFZ as a Biosafety Officer in 2013.
  21. Ursula Jenal

    Ursula Jenal

    Working address:

    Jenal & Partners Biosafety Consulting,
    Magdenerstrasse 1
    4310 Rheinfelden
    Switzerland

    Tel:+41 61 723 28 58
    Email:ursula.jenal@jenalpartners.ch

    Academic Education and Degrees


    PhD in Microbiology from the Swiss Federal Institute of Technology, ETH, Zürich,
    Post Doc in Environmental Engineering and Sciences at Stanford University

    Present Professional Position

    Since 2001, executive manager of Jenal & Partners Biosafety Consulting advising in-dustry, academia and authorities on an international level on all issues related to bi-osafety and biosecurity: risk assessment of contained use activities; risk assessment of nano-bio-materials; environmental risk assessment for gene and cell therapy and re-combinant vaccine clinical trials and market authorisation applications; guidelines on safe use of cell cultures, plant pathogens, transport, waste treatment; biorisk manage-ment systems, crisis management, biorisk management audits, ISO140001 audits, bi-osafety training, safe procedure design, project management. She has been involved in capacity building projects in South East Asia.

    Special Remarks

    1996-2000 senior scientist at the Swiss Federal Office for the Environment acting as co-author of the Swiss Biotechnology Regulations harmonised with the corresponding EU directives.
    Member of EBSA since 2001, acting as secretary for 4 years, member of the Educa-tion and Training Working Group until 2018 and representing EBSA at the Biological and Toxins Weapons Convention meetings.
    Member of the certification body of IFBA representing EBSA 2016 – 2020.
    Co-chair of the CEN workshop process to develop the CWA16335 on BioSafety Pro-fessional (BSP) competence, and project leader for the development of ISO Technical Specification TS5441 Competence Requirement for Biorisk Management Advisors to be published in February 2023.
  22. Vibeke Vibeke Halkjaer-Knudsen

    Vibeke Vibeke Halkjaer-Knudsen

  23. Yaël Vanden Abeele

    E D U C A T I O N

    • BSc / Biomedical Laboratory Sciences HOWEST University-College 2014 – 2018
    • Advanced BSc / Bioinformatics HOWEST University-College 2018 – 2019
    • MSc / Molecular and Cellular Life Sciences Vrije Universiteit Brussel 2019 - 2022 

    E X P E R I E N C E

    • Interim Laboratory Technician Dublin City University / Dublin, Ireland / February 2018 – June 2018
      Professional bachelor internship on topic “Immunomodulating properties of Fasciola hepatica derived exosomes”.
      • Explant cell culturing: murine bone marrow derived macrophages
      • Protein extraction and analysis: BCA assay, Western Blot, ELISA
      • Molecular techniques: PCR & qPCR
    • Animal Caretaker VUB / Brussels, Belgium / Summer 2021
      Summer job at the VUB Animal Facility to acquire hands-on experience on acquired degrees for laboratory animal science.
      • Animal health checkups (mice) + humane endpoint evaluation
      • Logistics of animal facility
    • Junior biosafety and regulatory specialist Perseus / Ghent, Belgium / Summer 2022 – current day
      Started from an intern summer position to fully pledged junior biosafety advisor at Perseus, aiding academia, and companies alike to meet their biosafety requirements.
      • Team-based literature surveillance and biosafety-related research
      • Drafting biosafety documentation for national and international players
      • Auditing laboratories 

Register

Sorry, the registration period is over.

Prices

Ticket type Price
Member conference ticket 2024 € 605.00
Member conference ticket 2024 + conference dinner € 655.00
Member conference ticket 2024 + conference dinner + printed conference book € 705.00
Member conference ticket 2024 + printed conference book € 635.00
Non-Member conference ticket 2024 € 710.00
Non-member conference ticket 2024 + conference dinner € 780.00
Non-member conference ticket 2024 + conference dinner + printed conference book € 810.00
Non-member conference ticket 2024 + printed conference book € 740.00

                                    | EBSA member | non member
Register before
February 1st 2024
Super Early Bird
Conference ticket             |            440 €    |     570 €
Printed conference book  |              25 €    |       25 €
Conference dinner           |              65 €    |       65 €


Register before
March 1st  2024
Conference ticket             |            505 €    |     605 €
Printed conference book  |              30 €    |       30 €
Conference dinner           |              70 €    |       70 €

Register from
March 1st 2024 onwards
Conference ticket             |            605 €    |     710 €
Printed conference book  |              30 €    |       30 €
Conference dinner           |              70 €    |       70 €

All prices are including Belgian VAT